APA (7th ed.) Citation

Narang, T., Kamat, D., Thakur, V., Lavania, M., Singh, I., Ahuja, M., & Dogra, S. (2022). Equal rates of drug resistance in leprosy cases with relapse and recurrent/chronic Type 2 reaction: Time to revise the guidelines for drug‐resistance testing in leprosy? Clinical & Experimental Dermatology, 47(2), 297. https://doi.org/10.1111/ced.14884

Chicago Style (17th ed.) Citation

Narang, T., D. Kamat, V. Thakur, M. Lavania, I. Singh, M. Ahuja, and S. Dogra. "Equal Rates of Drug Resistance in Leprosy Cases with Relapse and Recurrent/chronic Type 2 Reaction: Time to Revise the Guidelines for Drug‐resistance Testing in Leprosy?" Clinical & Experimental Dermatology 47, no. 2 (2022): 297. https://doi.org/10.1111/ced.14884.

MLA (9th ed.) Citation

Narang, T., et al. "Equal Rates of Drug Resistance in Leprosy Cases with Relapse and Recurrent/chronic Type 2 Reaction: Time to Revise the Guidelines for Drug‐resistance Testing in Leprosy?" Clinical & Experimental Dermatology, vol. 47, no. 2, 2022, p. 297, https://doi.org/10.1111/ced.14884.